Blog Reactions
Firedoglake: Eshoo, AMSA, and Me: A Visit to the Senate to Stop Pro-PhRMA Bill
Blue Commonwealth - Front Page: FDL Action Health Care Update: Friday (11/6/09)
| For those catching up, this is the dustup that wigged out @AnnaEshoo, PhRMA & Roche on Nov 2 http://tinyurl.com/yd4en67 RT @janehamsher 19 days ago |
| RT .@Stranahan Jane Hamsher: Anna Eshoo's PhRMA boondoggle: The devil's in her details: http://ow.ly/yImM 11/3/2009 |
| RT @Stranahan: Jane Hamsher: Anna Eshoo's PhRMA Boondoggle: The Devil Is In Her Details http://ow.ly/yImM 11/2/2009 |
Eshoo, AMSA, and Me: A Visit to the Senate to Stop Pro-PhRMA Bill
Firedoglake —
... Eshoo’s bill will grant a 12 year monopoly to drug companies on biologic “drugs of the future,” whereas conventional drugs only have 5 years. And because of an “evergreening” provision (which Eshoo denies is included in her bill, but Henry Waxman insists is very much there when he condemned it) that monopoly can be extended by slight tweeks in the drugs. ...
Marcy Winograd: Jane Harman Profits from Anti-Generics Amendment She Helped Eshoo Pass
Firedoglake —
... Anna Eshoo (D-PhRMA) may be the author of the language granting drug companies endless monopolies on biologic drugs, but she couldn’t have done it without the help of her good friend Jane Harman. A new letter from the Marcy Winograd campaign says: ...
FDL Action Health Care Update: Friday (11/6/09)
Blue Commonwealth - Front Page —
... that "Anna Eshoo (D-PhRMA) may be the author of the language granting drug companies endless monopolies on biologic drugs, but she couldn't have done it without the help of her good friend Jane Harman." Hamsher urges everyone to ...
The Algebra of Need: Cancer, Biologics, PhRMA
Firedoglake —
... Senator Sherrod Brown and Congressman Henry Waxman introduced legislation that would give the manufacturers of biologics a five-year window to reap the profits of exclusivity – and then open the door to generic competitors. But they lost out to language from Senator Hagan and Rep. Eshoo, which would give the Genentech/Roches of this world twelve years of exclusivity – and then allows that exclusivity to be extended indefinitely, simply by changing to recommended dosage or administration of the drug. ...





